37 results
8-K
PYXS
Pyxis Oncology Inc
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
of Directors (the “Board”). The Board has determined that Dr. Palani qualifies as an independent director under the corporate governance standards
8-K
13oa7 ee2
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
424B3
e6184obx
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
31zmp97waic
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
wnz0x
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
abp3o6
24 May 23
Business combination disclosure
7:05am
425
rtkwapcmnr
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
a41sr3bar 0a
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
87vza
1 Nov 22
Shelf registration
4:51pm
8-K
0qyo45u3 lx
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am